Plain-English translation of NCT04200391 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether very low carbohydrate diets are safe for people with type 1 diabetes. Researchers want to understand if following this type of diet affects how well glucagon (a rescue medication used to treat severe low blood sugar) works in your body. The study involves eating a very low carb diet for 12 weeks and then having your body's response to glucagon measured in a controlled setting.
Some people with type 1 diabetes report excellent blood sugar control on very low carbohydrate diets, but doctors worry that eating very few carbs might affect how well glucagon works during emergencies. This trial will test whether this concern is real, so people can make informed choices about whether this diet is truly safe for them.
You likely qualify if…
You likely don't qualify if…
Over 12 weeks, you would receive delivered meals following a very low carbohydrate diet while your blood sugar is monitored. At the end of this period, you would come in for a special test where doctors will carefully lower your blood sugar and then give you an injection of glucagon to see how well your body responds to the medication. Throughout the study, your blood sugar patterns and overall health will be tracked closely.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States